v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2022
Jan. 31, 2022
Current assets:    
Cash and cash equivalents $ 269,493 $ 1,669,304
Short-term investments 949,883 374
Accounts receivable, net 106,380 101,491
Deferred contract acquisition costs, current 30,894 27,546
Prepaid expenses and other current assets 33,348 18,939
Total current assets 1,389,998 1,817,654
Property and equipment, net 33,031 24,918
Operating lease right-of-use assets 25,270 23,884
Deferred contract acquisition costs, non-current 44,429 41,022
Intangible assets, net 159,677 15,807
Goodwill 540,308 108,193
Restricted cash, non-current 64,207 2,747
Other assets 8,174 7,956
Total assets 2,265,094 2,042,181
Current liabilities:    
Accounts payable 14,469 9,944
Accrued liabilities 31,913 22,657
Accrued payroll and benefits 38,576 61,150
Operating lease liabilities, current 4,004 4,613
Deferred revenue, current 244,207 182,957
Total current liabilities 333,169 281,321
Deferred revenue, non-current 100,844 79,062
Operating lease liabilities, non-current 25,261 24,467
Other liabilities 66,004 6,543
Total liabilities 525,278 391,393
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock; $0.0001 par value; 50,000,000 shares authorized as of July 31, 2022 and January 31, 2022, and no shares issued and outstanding as of July 31, 2022 and January 31, 2022 0 0
Additional paid-in capital 2,549,614 2,271,980
Accumulated other comprehensive income (loss) (2,013) 454
Accumulated deficit (807,813) (621,673)
Total stockholders’ equity 1,739,816 1,650,788
Total liabilities and stockholders’ equity 2,265,094 2,042,181
Class A    
Stockholders’ equity:    
Common stock, value, issued 20 16
Class B    
Stockholders’ equity:    
Common stock, value, issued $ 8 $ 11